Background: Increased levels of phosphate and fibroblast growth factor-23 (FGF23) are
strong predictors of cardiovascular morbidity and mortality in patients with chronic kidney …

Background: Elevated fibroblast growth factor 23 (FGF23) levels are associated with
progression of chronic kidney disease (CKD) and increased mortality. Studies in individuals …

Background: Serum intact fibroblast growth factor 23 (FGF23) levels are progressively
increased in relation to the severity of kidney dysfunction. High serum intact FGF23 …

Background Elevated serum fibroblast growth factor 23 (FGF23) is strongly associated with
cardiovascular risk and mortality. Tenapanor, an inhibitor of gastrointestinal …

Background Elevated fibroblast growth factor-23 (FGF23) levels increase the risk of
cardiovascular diseases in patients with chronic kidney disease (CKD). We aimed to …

Background Cardiovascular risk is increased in patients with chronic kidney disease (CKD).
Fibroblast growth factor 23 (FGF23) has emerged as an important, independent predictor of …

Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …

Background High levels of circulating fibroblast growth factor 23 (FGF23) are associated
with chronic kidney disease (CKD) progression and high mortality. In the Phosphate …

Background In hemodialysis patients, high levels of Fibroblast Growth Factor 23 (FGF23)
predict mortality. Our study was designed to test whether the control of serum phosphate is …

Disturbances in phosphate homeostasis are common in patients with chronic kidney
disease. As kidney function declines, circulating concentrations of phosphate and the …